Skip to main content
. 2021 Jan 1;11(4):1690–1702. doi: 10.7150/thno.53691

Figure 4.

Figure 4

Classical and next-generation vaccine platforms used in development against SARS-CoV-2. Classical (conventional) include those that are based on vaccines already licensed and used in humans. The next generation vaccines do not require the actual viral particle and can be developed solely on the sequence of the antigenic viral proteins.